Role of chemotherapy in nasopharyngeal carcinoma

  • Fabiola Paiar Radiotherapy Unit, University of Florence, Florence, Italy.
  • Vanessa Di Cataldo Radiotherapy Unit, University of Florence, Florence, Italy.
  • Giacomo Zei Radiotherapy Unit, University of Florence, Florence, Italy.
  • Eleonora Monteleone Pasquetti Radiotherapy Unit, University of Florence, Florence, Italy.
  • Sara Cecchini Radiotherapy Unit, University of Florence, Florence, Italy.
  • Icro Meattini | icro.meattini@unifi.it Radiotherapy Unit, University of Florence, Florence, Italy.
  • Monica Mangoni Radiotherapy Unit, University of Florence, Florence, Italy.
  • Benedetta Agresti Radiotherapy Unit, University of Florence, Florence, Italy.
  • Carmine Iermano Radiotherapy Unit, University of Florence, Florence, Italy.
  • Pierluigi Bonomo Radiotherapy Unit, Casa di Cura S. Chiara, Florence, Italy.
  • Giampaolo Biti Radiotherapy Unit, University of Florence, Florence, Italy.

Abstract

Nasopharyngeal carcinoma (NPC) is a unique malignant head and neck cancer with clinical, demographic, and geographic features distinct from other head and neck epithelial malignancies. Non-keratinizing, poorly differentiated, and undifferentiated WHO types 2 and 3 is the most common subtypes of NPC. NPC is also characterized by its relatively high sensitivity to radiation, so that in the last decades radiotherapy (RT) has been the cornerstone of treatment. However, in the majority of cases NPC is discovered at locally advanced stage. The results are disappointing when RT alone is offered. The 5-year survival rates have been reported to be about 34-52%. The poor prognosis for advanced NPC led to increasing interests in exploring the use of chemotherapy (CT). NPC has been considered to be not only radiosensitive but also chemo-sensitive and has shown high response rate to various chemotherapeutic agents. Certainly, the treatment strategies for NPC will continue to change and evolve as a better understanding is gained of the molecular and immune mechanisms that drive this disease. We reviewed the current literature focusing on the role of CT and new-targeted agents.

Downloads

Download data is not yet available.
Published
2012-06-12
Section
Reviews
Keywords:
nasopharyngeal carcinoma, chemotherapy, induction chemotherapy, targeted agents.
Statistics
Abstract views: 1894

PDF: 1073
HTML: 439
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Paiar, F., Di Cataldo, V., Zei, G., Monteleone Pasquetti, E., Cecchini, S., Meattini, I., Mangoni, M., Agresti, B., Iermano, C., Bonomo, P., & Biti, G. (2012). Role of chemotherapy in nasopharyngeal carcinoma. Oncology Reviews, 6(1), e1. https://doi.org/10.4081/oncol.2012.e1